Primary Myelofibrosis - 26 Studies Found
Recruiting |
: Ruxolitinib Phosphate and Chemotherapy Given Before and After Reduced Intensity Donor Stem Cell Transplant in Treating Patients With Myelofibrosis :
|
Completed |
: A Long-Term Study of the Effects of Orally Administered SAR302503 in Patients With Myelofibrosis : Myelofibrosis : 2008-07-17 : Drug: SAR302503 (TG101348) orally administered, once a day |
Completed |
: Study of Ruxolitinib (INCB018424) Sustained Release Formulation in Myelofibrosis Patients : Myelofibrosis : 2011-04-21 : Drug: Ruxolitinib Ruxolitinib was supplied as SR and IR formulated tablets. |
Recruiting |
: Interferon-pegyle α2a Efficiency and Tolerance in Myelofibrosis : Myelofibrosis : 2016-08-26 |
Active, not recruiting |
: Lenalidomide for Patients With Myelofibrosis (MF) : Myelofibrosis : 2006-07-14 :
|
Completed |
: A Clinical Study of Ruxolitinib in Patients With Primary Myelofibrosis (PM), Post-polycythemia Vera (PV) Myelofibrosis, or Post-essential Thrombocythemia (ET) Myelofibrosis : Primary Myelofibrosis (MF) : 2014-03-12 : Drug: Ruxolitinib |
Active, not recruiting |
: JAK2 Inhibitors RUXOLITINIB in Patients With Myelofibrosis : Myelofibrosis : 2012-12-21 : Drug: Ruxolotinib Ruxolotinib doses calculated with platelets count and P450 cytochrome inhibitor HSCT f |
Active, not recruiting |
: Panobinostat and Ruxolitinib In MyElofibrosis (PRIME Trial) : Myelofibrosis : 2012-09-14 :
|
Recruiting |
: Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis : Myelofibrosis : 2016-09-30 : Other: Hematopoietic Stem Cell Transplant This observational study will compare outcomes of prospectivel |
Recruiting |
: JAK Inhibitor Before Donor Stem Cell Transplant in Treating Patients With Primary or Secondary Myelofibrosis :
|